|
NCBP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02419994707503E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17330000048987E-07 |
| Normal-vs-Stage2 |
8.06500000000154E-05 |
| Normal-vs-Stage3 |
5.85049997336995E-09 |
| Normal-vs-Stage4 |
5.11869990837965E-10 |
| Stage1-vs-Stage2 |
8.026200E-01 |
| Stage1-vs-Stage3 |
6.854400E-02 |
| Stage1-vs-Stage4 |
1.054380E-02 |
| Stage2-vs-Stage3 |
3.357600E-01 |
| Stage2-vs-Stage4 |
7.420100E-02 |
| Stage3-vs-Stage4 |
2.908800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.75469999536193E-09 |
| Normal-vs-AfricanAmerican |
3.015900E-04 |
| Normal-vs-Asian |
1.22410000003015E-06 |
| Caucasian-vs-AfricanAmerican |
9.732000E-01 |
| Caucasian-vs-Asian |
7.568800E-01 |
| AfricanAmerican-vs-Asian |
8.547200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93250002059153E-09 |
| Normal-vs-Female |
1.00170000072453E-08 |
| Male-vs-Female |
1.636840E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7691000000486E-06 |
| Normal-vs-Age(41-60Yrs) |
3.79709996778388E-09 |
| Normal-vs-Age(61-80Yrs) |
2.26929997015901E-09 |
| Normal-vs-Age(81-100Yrs) |
2.735900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.063800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.428500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.299400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.115000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.399200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.136200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.768500E-02 |
| Classical-VS-Follicular |
4.051600E-01 |
| Classical-VS-Other |
2.143000E-01 |
| Classical-VS-Normal |
3.47049999849247E-08 |
| Tall-VS-Follicular |
3.707200E-01 |
| Tall-VS-Other |
7.105000E-01 |
| Tall-VS-Normal |
1.17909999997057E-06 |
| Follicular-VS-Other |
4.183000E-01 |
| Follicular-VS-Normal |
1.88300000003583E-06 |
| Other-VS-Normal |
1.938060E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.92180000194264E-08 |
| Normal-vs-N1 |
7.05920000232396E-09 |
| N0-vs-N1 |
5.098400E-02 |
|
|
